Skip to content

Analysis of the Efficacy of Home-Based Lymphedema Therapy in Breast Cancer-Related Lymphedema

Analysis of the Efficacy of Home-Based Lymphedema Therapy in Breast Cancer-Related Lymphedema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115330
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-01-27
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer-related lymphedema

Interventions

Home-based treatment:Patients in this group received standardized comprehensive decongestive therapy (CDT) from a lymphedema therapist at their first session, consisting of four components: skin care,
Outpatient treatment group:Patients were required to attend the lymphedema clinic for comprehensive decongestive therapy, which included skin care, manual lymphatic drainage, low-stretch bandaging, an

Sponsors

The second affiliated hospital of Zhejiang University school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Developed upper limb lymphedema following breast cancer-related treatment, with limb circumference exceeding 2 cm compared to the contralateral side; 2. Age between 18 and 75 years; 3. Lymphedema stage I–II.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment; 2. Bilateral lymphedema; 3. Patients currently undergoing radiotherapy; 4. Patients with uncontrolled tumor; 5. Patients with contraindications to comprehensive decongestive therapy, such as congestive heart failure.

Design outcomes

Primary

MeasureTime frame
Affected upper limb volume;

Secondary

MeasureTime frame
Breast Cancer and Lymphedema Symptom Experience Index;Core Quality of Life Questionnaire;

Countries

China

Contacts

Public ContactZhu Jiasheng

The second affiliated hospital of Zhejiang University school of medicine

zhujiasheng321@sina.com+86 571 89713690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026